Abstract. Double intraperitoneal injections of methylazoxymethanol (MAM) in pregnant rats induce developmental brain dysgenesis with nodular heterotopia similar to human periventricular nodular heterotopia (PNH) and composed of hyperexcitable neurons. Here we analyzed the NMDA receptor complex and associated proteins in the heterotopic neurons of 2-to 3-month-old MAM-treated rats by means of a combined immunocytochemical/molecular approach. Our data demonstrated a clear reduction of p286-active form of ␣CaMKII and a selective impairment of both the targeting and the CaMKII-dependent phosphorylation of NR2A/B subunits in the postsynaptic membranes of the MAM-induced heterotopia. The reduced NR2A/B immunofluorescence of the cellular membrane was not due to reduced expression since it was decreased only in postsynaptic fractions but not in the homogenate. NMDA-NR1 and AMPA-GluR2/3 subunits, as well as PSD-95 and total ␣CaMKII protein levels, were not affected in MAM-treated rats, thus revealing that the overall composition of the postsynaptic fraction was not altered. These data clearly suggest that the molecular organization of the NMDA/␣CaMKII complex is selectively altered in the postsynaptic compartment of heterotopic neurons. This alteration can play a role in determining the hyperexcitability of brain heterotopia in MAM rats as well as in human patients affected by PNH.
INTRODUCTION
Human cerebral dysgeneses are developmental brain malformations that are increasingly recognized as a relevant cause of mental and neurological deficits, including epilepsy (1-3). Human patients surgically treated for drug-resistant focal epilepsy are affected by developmental brain dysgeneses in about 20% to 40% of cases (4, 5) . In particular, epilepsy is present in nearly all patients affected by periventricular nodular heterotopia (PNH), a cerebral dysgenesis characterized by nodular masses of gray matter located in close apposition to the periventricular germinative neuroepithelium (6) .
The antiproliferative agent methylazoxymethanol (MAM) acetate has long been used by different groups to produce developmental structural abnormalities in the cerebellum and cerebral cortex (7, 8) . In particular, cerebral heterotopia can be induced by the prenatal administration of MAM (8) . We have previously demonstrated that a double dose of MAM administered to rats on embryonic day 15 results in the induction of cerebral heterotopia similar to human PNH and contains hyperexcitable neurons (9, 10) . However, the cellular and molecular mechanisms underlying the neuronal hyperexcitability in MAM-induced heterotopia as well as in human PNH are largely unknown.
It has become increasingly evident that NMDA (Nmethyl-D-aspartate) subtypes of glutamate receptors are of particular interest because they are involved not only in synaptogenesis, neuronal circuitry formation, and synaptic plasticity, but also in the molecular pathogenesis of neurological disorders, including epilepsy (11, 12) . NMDA receptors are localized at the postsynaptic membranes, where they are clustered with both scaffolding proteins such as PSD-95 and signal transduction elements such as the alpha subunit of Ca 2ϩ /calmodulin-dependent protein kinase II (␣CaMKII; 13) and the tyrosine kinase src. ␣CaMKII binds directly the C-terminal domain of NR2A/B subunits of NMDA receptor (14, 15) , whereas PSD-95 interacts with their tSXV domain (16) . NMDA receptors are therefore dynamically associated with several signal transduction pathways that can be activated by the Ca 2ϩ -flux occurring upon receptor opening. The activation of this system will in turn tune the excitable response of the postsynaptic neuron.
In the present paper, we have analyzed both the protein level and intracellular compartmentalization of the NMDA receptor complex and associated proteins in order to get a more comprehensive understanding of the molecular aspects governing the intrinsic hyperexcitability of MAM-induced cerebral heterotopia. This was achieved by analyzing the heterotopic cerebral areas induced by MAM administration with immunocytochemistry, confocal immunofluorescence, and Western blot analysis of a purified subcellular fraction (Triton insoluble fraction [TIF] ), specifically enriched in postsynaptic density (PSD) proteins. With this combined approach, we demonstrate here that the targeting to the postsynaptic membrane of the NMDA-NR2A/B receptor subunits and the CaMKII-dependent phosphorylation processes are specifically affected in heterotopic brain areas of MAM-treated rats when compared to age-matched controls. These data suggest a role for NMDA receptor complex alterations in the hyperexcitability of cerebral heterotopia, thus offering a possible explanation of the molecular changes underlying the onset of epileptic discharges in human patients affected by PNH.
MATERIALS AND METHODS

MAM Administration and Cerebral Tissue Preparation
All experimental procedures were carried on with care to minimize discomfort and pain to treated rats, in accordance with the guidelines of the European Communities Council (Directive of November 24, 1986 , 86/609/EEC). Pregnant SpragueDawley rats received 2 MAM acetate intraperitoneal doses (15 mg/kg maternal body weight, in sterile saline) on embryonic day 15, the first injection at 12:00 a.m. and the second at 12:00 p.m., as previously reported (17) . On the same day, control pregnant rats were sham injected with the vehicle alone. The day after conception (as determined by vaginal smear) was designated embryonic day 1. Litters were born on day 22 or 23 of gestation, and the day of birth was designated postnatal day 1 (P1). No differences in gestational parameters, pups' weight, and litter size were observed. The pups were weaned at 3 weeks of age and housed under standard conditions with water and food ad libitum.
For the morphological analysis, 13 adult MAM-treated rats (aged 2 to 3 months) and 8 sham-operated and age-matched control rats were employed. The rats were deeply anesthetized with chloral hydrate (1 ml/ 100 g body weight of a 4% solution) and perfused with 1% paraformaldehyde, followed by 4% paraformaldehyde in 0.1 M phosphate buffered saline at pH 7.2 (PBS). Brains were removed from the skull, postfixed overnight, and cut with a vibratome into 40-to 50-m-thick coronal sections. Sections were collected in PBS in serial order. One series of sections was counterstained with 0.1% thionin for cytoarchitectural analysis and the adjacent sections were processed for immunocytochemistry. In addition, selected sections were processed for confocal immunofluorescence.
For Western blot and biochemical analysis, 14 young adult MAM-treated rats (aged 2 to 3 months) and 5 sham-operated and age-matched control rats were employed. After decapitation, the brains were immediately dissected from the skull and immersed in ice-cold artificial cerebrospinal fluid (NaCl 126 mM, KCl 3.5 mM, CaCl 2 mM, MgSO 4 2 mM, NaH 2 PO 4 1.2 mM, NaHCO 3 26 mM, glucose 10 mM) bubbled with 95% O 2 and 5% CO 2 . Coronal brain slices (400 m thick) were obtained with a vibratome and examined with a Nikon SMZ 1500 stereoscopic microscope. The cerebral areas containing the cortical, periventricular, and intra-hippocampal heterotopia were recognized from the surrounding normal cerebral areas and carefully dissected out under microscopic control. Cerebral tissues from MAM-treated and control rats were separately collected in oxygenated artificial cerebrospinal fluid for 30 min and then snap-frozen in liquid nitrogen.
Given the clear rostro-caudal gradient of the MAM-induced brain abnormalities (17) , 3 different cerebral areas were considered for both morphologic and Western blot analysis ( Fig.   1 ): 1) the rostral cortical areas, modestly affected by MAM treatment (Fig. 1A) ; 2) the sensory and motor areas containing the cortical heterotopia, and the adjacent periventricular and intra-hippocampal heterotopia (Fig. 1B, C) ; and 3) the caudal hippocampal formation without clear morphological abnormalities or heterotopic nodules (Fig. 1D) . In all experiments, data from these areas were compared to those obtained from corresponding cerebral areas of normal control rats.
Antibodies
The following antibodies were employed: 1) a polyclonal anti-active-p286-␣CaMKII antibody (Promega, Madison, WI); 2) a monoclonal anti-␣CaMKII antibody (Chemicon International Inc., Temecula, CA) raised in mouse against the ␣ subunit of Ca 2ϩ /Calmodulin-dependent kinase II; 3) a monoclonal anti-NR1 antibody, raised in mouse against residues 660-811 of the NMDAR1 receptor sequence (Chemicon International Inc.); 4) polyclonal anti-peptide antibodies against GluR2/3 subunits of the rat AMPA receptor, and against NR2A/B subunits of the rat NMDA receptor (Chemicon International Inc.); and 5) a monoclonal antibody against PSD-95 (Affinity BioReagents Inc., Golden, CO).
Immunocytochemistry
The vibratome sections were immersed in 25% sucrose and 10% glycerol in PBS and then frozen at Ϫ80ЊC to increase the penetration of antibodies and reagents. Sections were then pretreated with 1% H 2 O 2 in PBS to neutralize the endogenous peroxidase activity, rinsed in PBS, and incubated with 10% normal goat or horse serum (NGS or NHS) for 60 min to mask nonspecific adsorption sites. Sections were then incubated overnight at room temperature in the primary antisera: 1) monoclonal anti-NR1 antibody (diluted 1:500); 2) polyclonal anti NMDA NR2A/B antibody (diluted 1:500); 3) monoclonal anti␣CaMKII antibody (diluted 1:300); and 4) polyclonal anti-active ␣CaMKII antibody (diluted 1:300). After rinsing for 2 h in PBS, the sections were incubated with biotinylated anti-mouse or anti-rabbit IgG (diluted 1:200) for 75 min and then rinsed for 1 h in PBS. The sections were then incubated for 1 h with Extravidin (1:5,000, Sigma, St. Louis, MO). All immunoreagents were diluted in 1% normal serum in PBS. Peroxidase staining was obtained by reacting the sections in a solution containing 3-3Ј-diaminobenzidine (0.075%) and H 2 O 2 (0.002%) in 50 mM-Tris-HCl buffer at pH 7.6. Sections were mounted onto gelatin coated glass slides, air-dried, dehydrated, and coverslipped with DPX. Slides were then analyzed and photographed with a Nikon Microphot FXA microscope.
For immunofluorescence experiments, selected sections from the heterotopic cerebral areas of MAM-treated rats and from corresponding areas of control rats were pretreated with 4% sucrose in PBS, then with 100% methanol for 30 min, and then frozen at Ϫ80ЊC to increase the penetration of antibodies. The sections were then incubated overnight at 4ЊC with the anti-NR2A/B primary antibody, diluted 1:100. The sections were then incubated for 2 h with Alexa Fluor R 488 GAR (Molecular Probes, Eugene, OR; diluted 1:2,000), repeatedly rinsed, mounted on slides, coverslipped with Fluorsave (Calbiochem, Darmstadt, Germany) and examined on a Radiance 2100 confocal microscope (Bio-Rad, Hercules, CA).
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Triton Insoluble Fraction
Tissue was homogenized in ice-cold sucrose 0.32 M containing Hepes 1 mM, MgCl 2 1 mM, NaHCO 3 1 mM, PMSF 0.1 mM, at pH 7.4 in presence of a complete set of proteases inhibitors (Complete, Boehringer Mannheim GmbH, Mannheim, Germany) and phosphatases inhibitors. The homogenized tissue was centrifuged at 1,000 ϫ g for 10 min. The resulting supernatant was centrifuged at 3,000 ϫ g for 15 min to obtain a fraction of mitochondria and synaptosomes (P2 fraction). The pellet was resuspended in hypotonic buffer in a glass-glass potter and centrifuged at 100,000 ϫ g for 1 h. The pellet was resuspended in buffer containing 75 mM KCl and 1% Triton-X 100 and centrifuged at 100,000 ϫ g for 1h. The final pellet was homogenized in a glass-glass potter in 20 mM Hepes. Then, an equal volume of glycerol was added and this TIF was stored at Ϫ80ЊC.
Cloning, Expression, and Purification of Glutathione S-Transferase Fusion Proteins
PSD-95 (54-256) fragment containing the PDZ1 and PDZ2 domains was subcloned downstream of Glutathione S-Transferase (GST) in the BamHI and HindIII site of the expression plasmid pGEX-KG by PCR using the Pfu polymerase (Stratagene, La Jolla, CA) on a cDNA containing plasmid for PSD-95 (kindly provided by M. Sheng). GST-PSD-95 (54-256) was expressed in E. coli and purified on glutathione agarose beads as previously described (18) .
''Pull Out'' Assay
Aliquots containing 10 g of TIF proteins were diluted with PBS, 0.1% SDS to a final volume of 1 ml and incubated (1 h, 37ЊC) with glutathione-agarose beads saturated with GST-PSD-95 (54-256) or GST alone. After incubation, the beads were extensively washed in 0.1% Triton X-100 in PBS (18) . Bound proteins were resolved by SDS-PAGE and subjected to immunoblot analysis with polyclonal anti-NR2A/B and monoclonal anti-␣CaMKII antibodies.
CaMKII-Dependent Phosphorylation and Immunoprecipitation Studies
Endogenous CaMKII-dependent phosphorylation and immunoprecipitation assays were performed as previously described (19) . Briefly, 10 g of TIF proteins were incubated in a buffer solution containing Hepes 20 mM pH 7.4, MgCl 2 10 mM, Okadaic acid 10-5 M (Sigma), phenyl-methyl-sulfonyl fluoride (PMSF) 100 M, DTT 20 mM with 100 M of ␥ 32 P-ATP (2 Ci/tube; 5,000 Ci/mmol; APBiotech, Uppsala, Sweden) in presence of 1 mM CaCl 2 and 40 g/ml calmodulin. Reactions were carried out at 37ЊC for 5 min and then stopped by immersion in liquid nitrogen. For immunoprecipitation, phosphorylated TIF proteins were incubated overnight at 4ЊC in buffer A (containing NaCl 200 mM, EDTA 10 mM, Na 2 HPO 4 10 mM, NP-40 0.5%, SDS 1% in a final volume of 400 l) with the anti-NR2A/B antibody diluted 1:100. Protein A-agarose beads (5 mg/tube), washed in the same buffer, were added and incubation was continued for 2 h. The beads were collected by centrifugation and washed 3 times with buffer A. Sample buffer for SDS-PAGE was added and the mixture was boiled for 3 min. Beads were pelleted by centrifugation and a volume of supernatants was loaded to SDS-PAGE 6%.
Data Analysis and Statistical Evaluation
Quantitation of Western blot analysis was performed by means of computer assisted imaging (Quantity-OneR System; Bio-Rad) and statistical evaluations were performed according to one-way analysis of variance (ANOVA) followed by Bonferroni as post hoc comparison test.
RESULTS
Decreased NR2A/B and ␣CaMKII Immunoreactivity in the Postsynaptic Membranes of MAM-Induced Heterotopic Neurons
We have previously demonstrated that the double MAM administration on embryonic day 15 consistently produced intra-cortical, periventricular, and intra-hippocampal heterotopia (17) . In the present study, we have analyzed the cortical immunoreactivity of NMDA glutamate receptor subunits NR1 and NR2A/B and ␣CaMKII in MAM-treated and control rats. As shown in Figure 2A , the NR1 staining was present throughout all cortical layers of control rats and it was particularly intense in the pyramidal neurons of layer V ( Fig. 2A) . NR1 immunoreactivity was also present in the MAM-induced intracortical (Fig. 2B) and periventricular (Fig. 2C) heterotopia within the sensory and motor cortical areas (at the rostro-caudal level shown in Fig. 1B) . Although the NR1 staining was more unevenly distributed in the heterotopic cortex as a consequence of the MAM-induced disorganization of the cortical layers, no differences in the immunoreactive signal were present at the cellular level between heterotopic and control neurons ( Fig. 2A-C) .
The NR2A/B staining was also present throughout all cortical layers of sham-operated control rats and was particularly conspicuous in the cytoplasm of layer V pyramidal neurons (Fig. 2D) . As for NR1, the NR2A/B staining was more unevenly distributed in the cortex of MAM-treated rats (Fig. 2E, F) . The cortical and subcortical heterotopia (at the rostro-caudal level shown in Fig.  1B ) were characterized by a slightly more intense neuropil staining (Fig. 2E) and by the presence of marginally placed neurons with more intense cytoplasmic labeling than that observed in neurons within the core of the heterotopia (Fig. 2F) . Even if the heterotopic neurons were characterized in some rats by a slightly less intense cytoplasmic labeling (compare Figs. 2D and 2E), our immunocytochemistry experiments did not reveal clear-cut differences in the overall NR2A/B staining between MAM-treated rats and controls.
Therefore, confocal immunofluorescence experiments were performed to better investigate the expression and subcellular localization of NR2A/B subunits at the cellular level. These experiments revealed that in the layer (het) (B, C) ; and the caudal hippocampal formation (hip) with no morphological abnormalities (D). Cortical and hippocampal areas were also prepared from control rats at corresponding rostro-caudal levels (not shown).
V pyramidal neurons of control rats the immunofluorescence signal was not only present in the cytoplasm (Fig.  3A) but it was clearly detectable also along the external cellular membrane of cell bodies and dendrites (Fig. 3A) . In MAM-treated rats, the NR2A/B signal was still evident, even if less clearly, along the cellular membrane of pyramidal neurons in the rostral cortical areas or outside the heterotopia (Fig. 3B) . By contrast, in the heterotopic pyramidal neurons, the NR2A/B labeling was still evident in the cytoplasm of the cell body and proximal dendrites, but it was barely appreciable at the postsynaptic membrane (Fig. 3C) .
The immunoreactivity for ␣CaMKII was also reduced in the same heterotopic cortical areas of MAM-treated rats (Fig. 4B ) in comparison to corresponding cortical areas of control rats (Fig. 4A) . In particular, the antibody E, F, arrows) . The cortical and subcortical heterotopia were characterized by a slightly more intense neuropil staining (E, arrowheads) and by the presence of more intensely labeled marginally placed neurons (F, arrowheads). Note that some heterotopic neurons displayed a slightly less intense perikaryal labeling (D, E, arrows). Calibration bars: 100 m.
against ␣CaMKII labeled in the control cortices the cell body and apical dendrites of pyramidal neurons, more conspicuously in layers II and III (Fig. 4A, insert) . Neurons from both the superficial cortical layers and the deep cortical heterotopia of MAM-treated rats displayed a less intense perikaryal and dendritic staining (Fig. 4B, insert) . A more dramatic difference was observed with the antip286-␣CaMKII antibody, which specifically recognizes the phospho-thr286 activated form of ␣CaMKII (Fig. 4C,  D) . Intense p286 labeling was present in the pyramidal neurons of control rats, particularly evident in the basal and apical dendrites (Fig. 4C, insert) . By contrast, in the heterotopic neurons of MAM-treated rats, the perikaryal labeling of the pyramidal neurons was less intense and the dendritic staining was barely appreciable (Fig. 4D,  insert) .
Altered Subcellular Compartmentalization of NR2A/B Subunits in MAM-Induced Heterotopia
To verify the protein level of glutamate receptors and PSD-associated signaling proteins such as ␣CaMKII, Western blot analysis was performed in TIF fractions prepared from brain slices of MAM-treated and control rats. The slices were obtained with a vibratome from the rostral cortical areas (Fig. 1A) , the sensory and motor areas containing the heterotopia (Fig. 1B, C) , and the caudal hippocampal formation without heterotopic nodules (Fig. 1D) . The cortical and subcortical heterotopia were always easily recognizable at the stereoscopic microscope from the adjacent cerebral areas. Therefore, the cerebral specimens dissected out from the slices for the preparation of TIF fractions were indeed characterized by the same histopathological features described above by our morphologic experiments. We used the TIF fraction instead of the classical PSD preparation because the amount of the starting material was very limited. The protein composition of this preparation was, however, carefully tested for the absence of presynaptic markers (i.e. synaptophysin and synaptotagmin; data not shown; 15).
Similar protein yield was obtained in TIF purified from MAM-treated and control rats and the same amount of TIF protein was applied to SDS-gel and electroblotted for both groups. As shown in Figure 5A , B, the immunoreactive signals for the NR1 subunit of NMDA receptor was not modified in TIF obtained from the different brain areas from MAM-treated rats when compared to controls; also AMPA-GluR2/3 subunit was unchanged in all groups, thus suggesting that the overall composition of the TIF fraction was not affected by embryonic MAM treatment. In addition, the concentration of proteins known to be highly enriched in the TIF fraction (15) (e.g. PSD-95 and ␣CaMKII) was similar for both groups in all the examined brain areas (Fig. 5) . However, a specific and significant reduction in NMDA-NR2A/B immunoreactivity was clearly present in the TIF fraction from the heterotopic areas of MAM-treated rats (Fig. 6A, B ) when compared to corresponding areas (frpar) of control rats (Ϫ63.1% Ϯ 5.2%, *p Ͻ 0.01, n ϭ 8 for each group). By contrast, no differences between MAM-treated and control rats were found in TIF fractions from both the rostral cortex (ros) and the caudal hippocampal formation (hip), that is, from cerebral areas not affected by the MAM treatment (Fig. 6A, B) .
To ascertain whether the decrease in NR2A/B immunostaining in the TIF fraction from MAM-induced heterotopic neurons was due to decreased expression or altered targeting of these subunits in postsynaptic membranes, we investigated in Western blot experiments the NR2A/B immunostaining in 3 different subcellular compartments obtained from heterotopic areas of MAM rats: the homogenate, the P2 fraction (corresponding to the crude membrane compartment), and the purified TIF fraction. As shown in Figure 6C , D, we found a specific and significant reduction of NR2A/B immunostaining (Fig. 6C, D) only in the TIF fraction, whereas no significant differences were present in both the homogenate and the P2 fraction (Ϫ64.2% Ϯ 5.9%; *p Ͻ 0.01, n ϭ 8 for each group). These findings reveal an altered compartmentalization of the NR2A/B regulatory subunits of the NMDA receptor complex that is specific for the heterotopic areas of MAM-treated rats, thus suggesting that prenatal MAM treatment has affected targeting rather than expression of these subunits.
Altered ␣CaMKII-Dependent Phosphorylation of NMDA Receptor Complex in MAM-Induced Heterotopia
In the last few years, different classes of signaling proteins (particularly ␣CaMKII) have been shown to be associated with and to phosphorylate the NR2A and 2B subunits of the NMDA receptor (14, 15) . Therefore, we investigated the effects of our prenatal MAM treatment on ␣CaMKII autophosphorylation and CaMKII-dependent phosphorylation of NR2 subunits in the TIF fraction from MAM-induced heterotopic areas. The basal autophosphorylation state of the kinase was analyzed in TIF fractions from control and MAM-treated rats by means of an anti-active-p286-␣CaMKII polyclonal antibody. As shown in Figure 7A , p286-␣CaMKII immunostaining was barely detectable in MAM heterotopic areas as compared to corresponding areas (frpar) of control rats (n ϭ 8 for each group). A decrease in p286-␣CaMKII immunostaining was also found in the rostral cortex of MAMtreated rats as compared to controls, whereas no difference was present in hippocampal region (Fig. 7A) . To confirm the reduction of ␣CaMKII autophosphorylation and to verify whether this event was paralleled by an altered phosphorylation of endogenous substrates such as NR2A/B subunits, TIF fractions from heterotopic areas and caudal hippocampus of MAM rats and from corresponding areas of controls were incubated under conditions known to activate Ca 2ϩ /CaM dependent phosphorylation and then immunoprecipitated with a polyclonal NR2A/B antibody. Equal amounts of TIF proteins were immunoprecipitated from control and MAM-treated rats, and the identity of NR2A/B subunits and ␣CaMKII in the immunocomplex was checked by Western blot analysis with specific antibodies (Fig. 7B, left lanes) . As shown in Figure 7B (right lanes), the 32 P-phosphate incorporation in the 50 kDa band, corresponding to ␣-CaMKII autophosphorylation (19) , was barely detectable in the MAM-induced heterotopic areas when compared to the corresponding areas of control rats (frpar). A quantitatively similar dramatic decrease was observed for the CaMKII-dependent phosphorylation of the 170 kDa- NR2A/B protein band. By contrast, no changes in the CaMKII-dependent phosphorylation were found in the hippocampus of MAM-treated rats when compared to controls (Fig. 7B) .
PSD-95 Association to NR2A/B Subunits of NMDA Receptor
NMDA-NR2A/B subunits directly interact with PSD-95 through their extended intracellular COOH sequence in the postsynaptic compartment (16) . These interactions induce the clustering of channel proteins (20) , and they are important in coupling the NMDA receptor to several biochemical intracellular pathways (21, 22) . To test whether PSD95-NR2A/B association could be affected in MAM-induced heterotopic neurons, fusion protein between GST and PSD-95 (54-256), encompassing the PDZ1 and PDZ2 domains of PSD-95, was used for a ''pull-out'' assay with solubilized TIF proteins as previously described (18) . As shown in Figure 8 , the capability of PSD-95 to bind the C-terminal domain of NR2A/B subunits of NMDA receptor was impaired in the heterotopic areas of MAM-treated rats when compared to the corresponding areas (frpar) of control rats, thus further supporting our data indicating an altered NR2A/B compartmentalization in MAM-induced heterotopic areas. The binding is specific since no NR2A/B subunits are pulled out using GST alone (data not shown). Moreover, the association of NR2A/B to GST-PSD-95 was not due to incomplete solubilization of the TIF proteins offered to the beads since another TIF protein such as ␣CaMKII (lower panel) remained in the supernatant in the pull-out assay (Fig. 8) . 
DISCUSSION
The present experiments have been undertaken to investigate the molecular basis of the intrinsic hyperexcitability observed in MAM-induced cerebral heterotopia (23) (24) (25) (26) (27) (28) (29) by using a combined morphologic and molecular approach. They demonstrate that the MAM-induced heterotopia are characterized by reduction of ␣CaMKII activity and alteration of the targeting and proper assembly of the NMDA-NR2A/B receptor subunits to the postsynaptic membrane.
The ␣CaMKII Activity is Reduced in Cerebral Heterotopia
Our immunocytochemistry data pointed out a clear reduction of ␣CaMKII in the MAM-induced heterotopic areas that was particularly conspicuous for the activated autophosphorylated form of the kinase and in the dendritic compartment, that is, in the cellular compartment containing the bulk of glutamatergic postsynaptic sites (Fig. 4) . Our biochemical and molecular data on triton insoluble fractions confirmed the results obtained at the morphological level, demonstrating a clear reduction of the p286-activated form of ␣CaMKII in heterotopic areas (Fig. 7) . Similarly, a selective and specific impairment of the CaMKII-dependent phosphorylation of NR2A/B subunits and ␣CaMKII autophosphorylation was demonstrated by in vitro phosphorylation and immunoprecipitation assays (Fig. 7) .
Heterotopic neurons in MAM rats display hyperexcitable behavior with long-lasting ''tonic'' discharges of action potentials in response to low amplitude depolarizing intracellular pulses (9, 17) . In addition, MAM-treated rats possess a clearly reduced threshold to a wide variety of pro-convulsing agents (23) (24) (25) 30) . Is there a causal relationship between the intrinsic hyperexcitability of MAM rats and the altered CaMKII function reported here? It should be remembered that decreased CaMKII activity has been long reported in different experimental conditions of neuronal hyperexcitability and epileptogenesis, such as kindling and bicuculline-or pilocarpineinduced status epilepticus (31) (32) (33) . The association between CaMKII activity and neuronal hyperexcitability was further underscored by the fact that transgenic mice carrying a null mutation of ␣CaMKII were characterized by epileptic seizures involving the limbic system (34) . In addition, in cultured hippocampal neurons the induction by low Mg 2ϩ of spontaneously recurrent epileptic-like discharges was associated with long-lasting decrease in neuronal ␣CaMKII expression (35) . Finally, a causal relationship between decreased CaMKII activity and neuronal hyperexcitability was established by the demonstration that the administration of anti-sense oligonucleotides for ␣CaMKII was able to induce the onset of epilepticlike discharges in cultured hippocampal neurons (36) . Supporting these findings, the present observations suggest that decreased ␣CaMKII autophosphorylation may indeed play a role also in the development of neuronal hyperexcitability in experimentally induced heterotopia. Even if it is likely that other mechanisms are involved (9, 29, 37) , it is tempting to hypothesize that similar molecular changes also take place in human epilepsy associated with brain heterotopia. To this end, we have previously provided strong evidence that MAM-treated rats are a good model for human PNH (17) , and that epileptogenic heterotopic nodules from surgically treated PNH patients are characterized by reduced expression of activated ␣CaMKII (38). This fact not only further demonstrates the similarity between cerebral heterotopia in MAM-treated rats and human PNH, but it also suggests that alterations in ␣CaMKII-NMDA transduction pathway may be indeed an important part of the long-term plasticity changes associated with the development of epilepsy in human brain dysgeneses.
The NMDA Receptor Complex is Altered in Cerebral Heterotopia
Previous immunocytochemical and in situ hybridization experiments have suggested changes in glutamate receptor subunits in both MAM-induced heterotopia and human brain dysgenesis (39) (40) (41) . Our experiments demonstrated relevant molecular alterations in the glutamatergic sites of heterotopic areas. In contrast to the correct concentration of NMDA-NR1 and AMPA-GluR2/3 subunits and PSD-95 (Fig. 5) , there was a considerable decrease in NMDA-NR2A/B immunoreactivity in the TIF purified from heterotopic areas (Fig. 6 ). This indicates that MAM treatment has not altered the gross structure of the triton insoluble fraction, but it has selectively affected the NR2A/B subunit protein levels. Interestingly, the depletion of NR2A/B was restricted to the TIF fraction and was not found in the homogenate and crude membrane (P2) fractions of MAM rats. The Western blot data were confirmed by the confocal immunofluorescence analysis demonstrating that in heterotopic pyramidal neurons of MAM-treated rats the NR2A/B signal was similar in the cytoplasm, but strongly reduced at the postsynaptic membrane if compared to that observed in pyramidal neurons of control rats. Taken together, these data strongly support the concept that MAM treatment does not affect NR2A/B protein expression, but rather the correct targeting of these subunits and the assembly of NMDA receptors.
It has been recently demonstrated that the trafficking of NMDA receptors to the postsynaptic membrane of CA1 hippocampal neurons of adult rats after the induction of long-term potentiation (42) . The data provided here lend further support to the concept that the correct assembly of the NMDA receptor complex can represent a target of pathological processes involving the brain, as it has been recently observed in a 6-OH model of Parkinson disease (43) . As a further indication of postsynaptic modifications caused by MAM treatment in heterotopic neurons, we show here that NR2A/B protein level in MAM rats is paralleled by an impaired association of these receptor subunits to PSD-95 PDZ domains (Fig. 8) .
We have already demonstrated in human epileptic patients with particularly pronounced nodular heterotopia, a decrease in NR2A/B immunoreactivity in the dendrites of heterotopic neurons (38) . The latter finding together with the evidence provided by the present experiments point out the possibility that in both experimentally induced heterotopia as well as in human PNH, the alteration of the NMDA receptor complex may indeed have a causal role in determining the intrinsic hyperexcitability of heterotopic neurons. This hyperexcitability can in turn determine the clinical onset of epileptic discharges through the electrophysiologic recruitment of cortical and subcortical neurons via the altered circuitry linking the heterotopic nodules to the adjacent neocortical and archicortical areas (10, 44) .
